Press
Outpost Bio Raises $3.5 M Pre-Seed to Build Frontier Models for Human Microbiology
Outpost Bio Raises $3.5 M Pre-Seed to Build Frontier Models for Human Microbiology
The company is building frontier AI models trained on proprietary data from human-derived microbial communities. Its Lab-in-the-Loop platform combines high-throughput biological assays with causal AI to predict how molecules interact with the human microbiome — enabling any partner developing molecules that go into or onto humans to predict microbe-mediated metabolism, toxicity, and response.
The company is building frontier AI models trained on proprietary data from human-derived microbial communities. Its Lab-in-the-Loop platform combines high-throughput biological assays with causal AI to predict how molecules interact with the human microbiome — enabling any partner developing molecules that go into or onto humans to predict microbe-mediated metabolism, toxicity, and response.
Outpost Bio, a deep-tech company making human microbiology computable, today announced its $3.5M pre-seed funding round led by Seedcamp and Merantix, with participation from OpenSeed VC and Defined Capital.
The company is building frontier AI models trained on proprietary data from human-derived microbial communities. Its Lab-in-the-Loop platform combines high-throughput biological assays with causal AI to predict how molecules interact with the human microbiome — enabling any partner developing molecules that go into or onto humans to predict microbe-mediated metabolism, toxicity, and response.
“We’re building the most comprehensive dataset in human microbiology,” said Jenny Yang, CEO & Co-Founder. “For the first time, we can move beyond correlations to reveal causal pathways that determine how the human body interacts with therapeutic and consumer compounds.”
Outpost Bio, a deep-tech company making human microbiology computable, today announced its $3.5M pre-seed funding round led by Seedcamp and Merantix, with participation from OpenSeed VC and Defined Capital.
The company is building frontier AI models trained on proprietary data from human-derived microbial communities. Its Lab-in-the-Loop platform combines high-throughput biological assays with causal AI to predict how molecules interact with the human microbiome — enabling any partner developing molecules that go into or onto humans to predict microbe-mediated metabolism, toxicity, and response.
“We’re building the most comprehensive dataset in human microbiology,” said Jenny Yang, CEO & Co-Founder. “For the first time, we can move beyond correlations to reveal causal pathways that determine how the human body interacts with therapeutic and consumer compounds.”
Related articles
Legal Pages
©OUTPOST BIO 2026
BAKED BY THE SOURDOUGH
©OUTPOST BIO 2026
BAKED BY THE SOURDOUGH